Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Supply Chain
cphipanel
GLP-1 demand puts strain on production capacity, supply chains
As injectable and oral GLP-1s evolve, pharma companies face tough choices about capacity, delivery platforms, outsourcing, and supply resilience, says CPHI Milan panel.
Oct. 7, 2026
chinauspillsfinal_shutterstock
Manufacturing of new FDA-approved drugs moving to China: GlobalData
Sept. 28, 2026
trump
Trump strikes drug pricing, tariff deals with nine mid-sized biopharma companies
Sept. 1, 2026
germanypillsshutterstock
German drug manufacturers face biggest hit from US supply chain bill: GlobalData
Aug. 18, 2026
fdawhiteoakbuilding
FDA’s GDUFA IV commitment letter supports onshoring of generic drug manufacturing
Aug. 13, 2026
departmentcommerceshutterstock
Department of Commerce funds biomanufacturing, pharma manufacturing hubs
July 22, 2026
congress_shutterstock
Senators sponsor bill seeking transparency on foreign control in US drug supply chain
July 17, 2026
fdawhiteoakbuilding
FDA proposed rule eases drug manufacturing registration, boosts foreign source visibility
July 13, 2026
chinauspillsfinal_shutterstock
US biotech leadership at risk as China dominates manufacturing: survey
June 23, 2026
Looking for Something?
Load More Content
